SNDX
Syndax Pharmaceuticals, Inc. · Healthcare
Chief Scientific Officer Peter Ordentlich sold $626K of Syndax Pharmaceuticals, Inc.
Sold$626,025
$25.04Price
25,000Shares
−99%Stake
What SNDX did after the filing
- The stock from Fri, Dec 2 close, $25.07
- +3.6%
- S&P 500, same days
- −3.3%
Measured over 30 trading days, to the Jan 18 close.
Traded Thu, Dec 1. Filed Fri, Dec 2, 12:01 PM ET, during the session. Returns use the Dec 2 close and the Jan 18 close. Not investment advice.